O

OnKure Therapeutics

13 employees

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2011

Funding rounds raised

Total raised

$57M

from 9 investors over 9 rounds

O

OnKure Therapeutics raised $54M on May 23, 2023

Investors: Surveyor Capital, Acorn Bioventures, Samsara BioCapital and Perceptive Advisors

O

OnKure Therapeutics raised $57M on March 4, 2021

Investors: Surveyor Capital, Perceptive Advisors, Acorn Bioventures and Samsara BioCapital

O

OnKure Therapeutics raised $7M on May 2, 2018

Investors: 北京德联运通投资管理有限公司

FAQ